UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2014, Volume 312, Issue 6, pp. 631 - 640
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hepacivirus - drug effects | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Prevalence | Antiviral Agents - therapeutic use | Coinfection - drug therapy | United States | Humans | Hepacivirus - genetics | Genotype | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Life Cycle Stages | Antiviral Agents - adverse effects | HIV Infections - complications | HIV Infections - drug therapy | Hepacivirus - physiology | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Patient safety | Hepatitis | Systematic review | Medical treatment
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 02/2020, Volume 70, Issue 4, pp. 674 - 675
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 11/2014, Volume 67, pp. 1 - 1
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 01/2016, Volume 71, p. 1
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 01/2016, Volume 71, p. 34
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2018, Volume 319, Issue 17, pp. 1802 - 1813
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Liver Neoplasms - prevention & control | Recombinant Proteins - therapeutic use | Liver Cirrhosis - drug therapy | United States - epidemiology | Antiviral Agents - therapeutic use | Hepatitis B, Chronic - epidemiology | Humans | Middle Aged | Risk Factors | Interferon-alpha - therapeutic use | Male | Hepatitis B, Chronic - diagnosis | Polyethylene Glycols - therapeutic use | Disease Progression | Hepatitis B Surface Antigens - blood | Hepatitis B, Chronic - drug therapy | Adult | Female | Therapy | Liver | Chronic infection | Viruses | Hepatocellular carcinoma | Infections | Mental depression | Drug resistance | Tenofovir | Analogs | Hepatitis | Liver cancer | Bone marrow | Hepatitis B virus | Deoxyribonucleic acid--DNA | Hepatitis B surface antigen | Liver diseases | Risk reduction | Lamivudine | Patients | DNA biosynthesis | Cirrhosis | Side effects | Adefovir | Fibrosis | Interferon | Liver cirrhosis | Antiviral drugs
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 04/2014, Volume 65, pp. 1 - 1
Journal Article
Gastroenterology clinics of North America, ISSN 0889-8553, 06/2020, Volume 49, Issue 2, pp. 191 - 199
Acute liver failure | Hepatitis A virus | Hepatitis A outbreak | Hepatitis A prevention | Hepatitis A vaccine | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Abdominal Pain - etiology | Hepatitis A - epidemiology | Humans | Risk | Alanine Transaminase - blood | Biomarkers - blood | Hepatitis A Vaccines | Serologic Tests - methods | Travel | Anorexia - etiology | Hepatitis A - prevention & control | Hepatitis A - complications | Hepatitis A - diagnosis | Jaundice - etiology
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2018, Volume 320, Issue 11, pp. 1202 - 1202
Journal Article
10.
In reply
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2018, Volume 320, Issue 11, p. 1202
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 11/2014, Volume 67, p. 39
Journal Article
Gastroenterology & hepatology, ISSN 1554-7914, 03/2018, Volume 14, Issue 3, pp. 186 - 188
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 04/2014, Volume 65, Issue Suppl 2, pp. 68 - 68
Journal Article
14.
Full Text
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics
Frontiers in immunology, ISSN 1664-3224, 10/2020, Volume 11, pp. 2013 - 2013
Journal Article
Frontiers in immunology, ISSN 1664-3224, 09/2020, Volume 11, pp. 569611 - 569611
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 9, pp. 1049 - 1054
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Sofosbuvir - therapeutic use | Humans | Middle Aged | Fluorenes - therapeutic use | Hepacivirus - genetics | Genotype | Male | Hepatitis C, Chronic - drug therapy | Viral Load | DNA, Viral - blood | Female | Aged | Fluorenes - adverse effects | Sofosbuvir - adverse effects | Benzimidazoles - adverse effects | Drug Combinations | Benzimidazoles - therapeutic use | Clinical trials | Arab countries | Hepatitis C virus | Hepatitis C | Health aspects | Analysis | Hepatitis | Genotype & phenotype | Infectious diseases | Liver diseases | Research & development--R&D | Laboratories | Interferon | Infections | Liver cirrhosis | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1107 - 1113
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Fluorenes - therapeutic use | Hepacivirus - genetics | Male | RNA, Viral - blood | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Furans - therapeutic use | Viral Load | Drug Therapy, Combination - methods | Uridine Monophosphate - analogs & derivatives | Intention to Treat Analysis | Female | Aged | Quinolines - therapeutic use | Sofosbuvir | Benzimidazoles - therapeutic use | Cohort Studies | Uridine Monophosphate - therapeutic use | Clinical trials | Antiviral agents | Hepatitis C | Drug therapy | Hepatitis C virus | Hepatitis | Genotype & phenotype | Drug dosages | Clinical outcomes | Virology | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 6/2015, Volume 60, Issue 12, pp. 1743 - 1751
ARTICLES AND COMMENTARIES | direct-acting antiviral | HCV RNA | viral load | hepatitis C | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hepacivirus - drug effects | Predictive Value of Tests | Antiviral Agents - pharmacology | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Middle Aged | Male | RNA, Viral - blood | Drug Monitoring - methods | Hepatitis C - epidemiology | Hepatitis C - virology | Adult | Female | Aged | Viral Load - drug effects | Measurement | Usage | Viremia | Interferon | Dosage and administration | Hepatitis C virus | Risk factors | Hepatitis | Drug therapy | Ribonucleic acid--RNA | Antiviral drugs | Medical treatment | Index Medicus | and Commentaries
Journal Article